232 related articles for article (PubMed ID: 11965235)
21. Immunomodulating antibodies and drugs for the treatment of hematological malignancies.
Houot R; Kohrt H; Goldstein MJ; Levy R
Cancer Metastasis Rev; 2011 Mar; 30(1):97-109. PubMed ID: 21271352
[TBL] [Abstract][Full Text] [Related]
22. Improving the efficacy of antibody-based cancer therapies.
Carter P
Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of therapeutic monoclonal antibodies: promises and pitfalls of in vitro and in vivo assays.
Golay J; Introna M
Arch Biochem Biophys; 2012 Oct; 526(2):146-53. PubMed ID: 22387378
[TBL] [Abstract][Full Text] [Related]
24. The coming of age of engineered multivalent antibodies.
Nuñez-Prado N; Compte M; Harwood S; Álvarez-Méndez A; Lykkemark S; Sanz L; Álvarez-Vallina L
Drug Discov Today; 2015 May; 20(5):588-94. PubMed ID: 25757598
[TBL] [Abstract][Full Text] [Related]
25. Approved monoclonal antibodies for cancer therapy.
Boyiadzis M; Foon KA
Expert Opin Biol Ther; 2008 Aug; 8(8):1151-8. PubMed ID: 18613766
[TBL] [Abstract][Full Text] [Related]
26. Chimeric antigen receptor T-cell immunotherapy tackles blood cancers.
Brower V
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838441
[No Abstract] [Full Text] [Related]
27. Monoclonal antibody therapy in haematological malignancies.
Chamuleau ME; van de Loosdrecht AA; Huijgens PC
Curr Clin Pharmacol; 2010 Aug; 5(3):148-59. PubMed ID: 20406175
[TBL] [Abstract][Full Text] [Related]
28. The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspective.
Baron F; Storb R
Best Pract Res Clin Haematol; 2006; 19(4):637-53. PubMed ID: 16997174
[TBL] [Abstract][Full Text] [Related]
29. Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method.
Khademi F; Mostafaie A; Parvaneh S; Gholami Rad F; Mohammadi P; Bahrami G
Int Immunopharmacol; 2017 Feb; 43():23-32. PubMed ID: 27939822
[TBL] [Abstract][Full Text] [Related]
30. Clinical development of 2B1, a bispecific murine monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.
Weiner LM; Clark JI; Ring DB; Alpaugh RK
J Hematother; 1995 Oct; 4(5):453-6. PubMed ID: 8581384
[TBL] [Abstract][Full Text] [Related]
31. G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).
Repp R; Valerius T; Wieland G; Becker W; Steininger H; Deo Y; Helm G; Gramatzki M; Van de Winkel JG; Lang N
J Hematother; 1995 Oct; 4(5):415-21. PubMed ID: 8581378
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody-based therapies for hematologic malignancies.
Multani PS; Grossbard ML
J Clin Oncol; 1998 Nov; 16(11):3691-710. PubMed ID: 9817291
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies as therapeutics in oncology.
Trikha M; Yan L; Nakada MT
Curr Opin Biotechnol; 2002 Dec; 13(6):609-14. PubMed ID: 12482522
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of Therapeutic Antitumor Monoclonal Antibodies.
Tsao LC; Force J; Hartman ZC
Cancer Res; 2021 Sep; 81(18):4641-4651. PubMed ID: 34145037
[TBL] [Abstract][Full Text] [Related]
35. Blocking tumor escape in hematologic malignancies: the anti-PD-1 strategy.
Bryan LJ; Gordon LI
Blood Rev; 2015 Jan; 29(1):25-32. PubMed ID: 25260226
[TBL] [Abstract][Full Text] [Related]
36. Advances in the treatment of hematologic malignancies using immunoconjugates.
Palanca-Wessels MC; Press OW
Blood; 2014 Apr; 123(15):2293-301. PubMed ID: 24578502
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic antibodies against cancer.
Adler MJ; Dimitrov DS
Hematol Oncol Clin North Am; 2012 Jun; 26(3):447-81, vii. PubMed ID: 22520975
[TBL] [Abstract][Full Text] [Related]
38. A pivotal decade for bispecific antibodies?
Surowka M; Klein C
MAbs; 2024; 16(1):2321635. PubMed ID: 38465614
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody therapy of haematological malignancies.
Dearden C
BioDrugs; 2002; 16(4):283-301. PubMed ID: 12196040
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapeutic approaches for hematologic malignancies.
Caligiuri MA; Velardi A; Scheinberg DA; Borrello IM
Hematology Am Soc Hematol Educ Program; 2004; ():337-53. PubMed ID: 15561691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
